Table II.
Advantage | Importance | Disadvantage | Importance |
---|---|---|---|
Rapid—many hundred measurements/day possible | High | Lack of API specificitya | High |
High size resolution (>10 channels/decade) | Moderate | Particle coincidence possible at high aerosol concentrations | Moderate |
Well-characterized sampling system with aerosol dilution possible | Moderate | Count (number)-rather than mass-weighted APSDs | High |
Continuous tracking of particles through measurement zone | High | Particle density bias | Moderate—mainly of concern with DPIs |
Particle shape bias | Moderate—mainly of concern with DPIs | ||
No simulation of inhalation | Low to moderate—needed to test spacers |
API active pharmaceutical ingredient, APSD aerodynamic particle size distribution, DPI dry powder inhaler, TOF time of flight
aWithout abbreviated impactor-inlet accessory